Related Experiment Video
Updated: Feb 10, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients
H B Østergaard1, T Mandrup-Poulsen2, G F N Berkelmans3
1Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Nørre Allé 22, 2200 Copenhagen N, Denmark.
Insights
Higher haemoglobin glycation index (HGI) increases cardiovascular disease (CVD) risk in type 2 diabetes patients without prior CVD. HGI offers limited additional clinical benefit over HbA1c due to complexity.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Syndrome
Background:
- The haemoglobin glycation index (HGI) reflects interindividual differences in haemoglobin glycosylation.
- Previous research links high HGI to increased cardiovascular disease (CVD) risk in diabetic patients.
- The impact of prior CVD on the HGI-CVD risk association remains unexamined.
Purpose of the Study:
- To investigate the association between HGI and cardiovascular events in patients with type 2 diabetes mellitus (T2DM).
- To determine if previous CVD influences the relationship between HGI and cardiovascular outcomes.
Main Methods:
- Utilized data from 1910 T2DM patients in the Second Manifestations of Arterial Disease (SMART) study.
- Employed Cox proportional-hazards models to assess HGI and HbA1c against composite cardiovascular events and mortality.
- Conducted analyses stratified by the presence or absence of previous CVD.
Main Results:
- A 1-unit increase in HGI correlated with a 29% higher risk of cardiovascular events in patients without prior CVD (HR: 1.29).
- No significant association was observed between HGI and cardiovascular events in patients with previous CVD (HR: 0.96).
- HGI and HbA1c demonstrated similar risk associations; HGI's clinical utility may be limited by complexity.
Conclusions:
- Elevated HGI is associated with increased cardiovascular event risk in T2DM patients without a history of CVD.
- The clinical benefit of HGI over HbA1c in risk prediction for T2DM patients appears limited.
- HGI's complexity in measurement and interpretation may restrict its widespread clinical application.
Background:
The haemoglobin glycation index (HGI) has been proposed as a marker of interindividual differences in haemoglobin glycosylation. Previous studies have shown a relationship between high HGI and risk of cardiovascular disease (CVD) in patients with diabetes. However, no studies have investigated the role of previous CVD in this association.
Methods:
The study cohort comprised patients with type 2 diabetes mellitus (T2DM; n=1910) included in the Second Manifestations of Arterial Disease (SMART) study. The relationship between either HGI or HbA1c and a composite of cardiovascular events as the primary outcome, and mortality, cardiovascular mortality, myocardial infarction and stroke as secondary outcomes, was investigated using Cox proportional-hazards models. Similar analyses were performed after stratification according to previous CVD.
Results:
A 1-unit higher HGI was associated with a 29% greater risk of a composite of cardiovascular events (HR: 1.29, 95% CI: 1.06-1.57) in patients without previous CVD, whereas no such relationship was seen in patients with previous CVD (HR: 0.96, 95% CI: 0.86-1.08). The direction and magnitude of the hazard ratios (HRs) of HGI and HbA1c in relation to outcomes were similar. Additional adjustment for HbA1c in the association between HGI and outcomes lowered the HRs.
Conclusion:
Similar to HbA1c, higher HGI is related to higher risk of cardiovascular events in patients with T2DM without CVD. As HbA1c has proved to be a comparable risk factor, and obtaining and interpreting the HGI is complicated, any additional benefit of applying the HGI in clinical settings is likely to be limited.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Types of Limits II
Types of Limits I
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

